NCT03297853 is a clinical trial in Analgesics Grade 2's Addiction, sponsored by University Hospital, Montpellier.

Who is sponsoring NCT03297853?

NCT03297853 is sponsored by University Hospital, Montpellier.

What condition does NCT03297853 study?

NCT03297853 studies Analgesics Grade 2's Addiction.

Is NCT03297853 still recruiting?

NCT03297853 is currently completed. Last updated 7 May 2018.

Last reviewed 2018-05-07 · How we verify

NCT03297853

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prevalence, Management and Follow-up of Patients With Addiction to Opioid Analgesics

Completed Last updated 7 May 2018

What this trial tests

trial in Analgesics Grade 2's Addiction in 64 participants. Completed in 30 March 2018.

Timeline

1 January 2014

Primary endpoint
31 July 2017

30 March 2018

Quick facts

Lead sponsor	University Hospital, Montpellier
Status	Completed
Study type	OBSERVATIONAL
Enrollment	64
Start date	1 January 2014
Primary completion	31 July 2017
Estimated completion	30 March 2018
Sites	1 location across France

Conditions studied

Analgesics Grade 2's Addiction — all drugs for Analgesics Grade 2's Addiction →

Sponsor

University Hospital, Montpellier

Who can join

18 and older, any sex, with Analgesics Grade 2's Addiction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The demand for addiction care for patients with addiction to analgesics increases with the number of prescription of analgesics grade 2; this is a public health problem There is no support for repositories to date in the context of addiction analgesics grade 2. Risk factors of misuse as well as diagnostic tools were identified.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University Hospital, Montpellier trials

Trials by the same sponsor.

NCT07524127 — Phenotyping of Type 2 Inflammation Profile by Rheology of Nasal Secretions and Tissue Quantification of Eosinophilic Pol · NA · not yet recruiting
NCT07255495 — Effects of Neuromuscular Scoliosis Surgery on Nutritional Metabolism · NA · not yet recruiting
NCT07534189 — Prospective Cohort Study Evaluating a Thermal Spa Programme in Symptomatic Knee Osteoarthritis · NA · not yet recruiting
NCT07515638 — Immun4Cure Cohort of Autoimmune Diseases · not yet recruiting
NCT07406516 — Identification of Kinematic Variables Specific of Patellar Tendinopathy in Athletes at Risk · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03297853 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Montpellier
Last refreshed: 7 May 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03297853.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing